Synthesis of novel siRNAs having thymidine dimers consisting of a carbamate or a urea linkage at their 3′ overhang regions and their ability to suppress human RNase L protein expression

2005 ◽  
Vol 330 (4) ◽  
pp. 1168-1175 ◽  
Author(s):  
Yoshihito Ueno ◽  
Tomoharu Naito ◽  
Koshi Kawada ◽  
Aya Shibata ◽  
Hye-Sook Kim ◽  
...  
2017 ◽  
Vol 91 (14) ◽  
Author(s):  
Melissa Drappier ◽  
Fred R. Opperdoes ◽  
Thomas Michiels

ABSTRACT Vilyuisk human encephalitis virus (VHEV) is a picornavirus related to Theiler's murine encephalomyelitis virus (TMEV). VHEV was isolated from human material passaged in mice. Whether this VHEV is of human or mouse origin is therefore unclear. We took advantage of the species-specific activity of the nonstructural L* protein of theiloviruses to track the origin of TMEV isolates. TMEV L* inhibits RNase L, the effector enzyme of the interferon pathway. By using coimmunoprecipitation and functional RNase L assays, the species specificity of RNase L antagonism was tested for L* from mouse (DA) and rat (RTV-1) TMEV strains as well as for VHEV. Coimmunoprecipitation and functional assay data confirmed the species specificity of L* activity and showed that L* from rat strain RTV-1 inhibited rat but not mouse or human RNase L. Next, we showed that the VHEV L* protein was phylogenetically related to L* of mouse viruses and that it failed to inhibit human RNase L but readily antagonized mouse RNase L, unambiguously showing the mouse origin of VHEV. IMPORTANCE Defining the natural host of a virus can be a thorny issue, especially when the virus was isolated only once or when the isolation story is complex. The species Theilovirus includes Theiler's murine encephalomyelitis virus (TMEV), infecting mice and rats, and Saffold virus (SAFV), infecting humans. One TMEV strain, Vilyuisk human encephalitis virus (VHEV), however, was isolated from mice that were inoculated with cerebrospinal fluid of a patient presenting with chronic encephalitis. It is therefore unclear whether VHEV was derived from the human sample or from the inoculated mouse. The L* protein encoded by TMEV inhibits RNase L, a cellular enzyme involved in innate immunity, in a species-specific manner. Using binding and functional assays, we show that this species specificity even allows discrimination between TMEV strains of mouse and of rat origins. The VHEV L* protein clearly inhibited mouse but not human RNase L, indicating that this virus originates from mice.


Author(s):  
Magdalena Petrová ◽  
Miloš Buděšínský ◽  
Eva Zborníková ◽  
Natalia Panova ◽  
Pavel Novák ◽  
...  
Keyword(s):  
Rnase L ◽  

Coronaviruses ◽  
2021 ◽  
Vol 02 ◽  
Author(s):  
Chellapandi P ◽  
Saranya S

: Coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new coronavirus isolated from Wuhan, China. It is a global health emergency, and there is no effective antiviral therapeutics available to date. Continuous structural genomic insights of SARS-CoV-2 proteins provide a warranty for the development of rational-based antivirals. Nevertheless, a structure-based drug candidate with multiple therapeutic actions would be a practical choice of medication in the treatment of severe COVID-19 patients. Cordycepin from medicinal fungi (Cordyceps spp.) and its nucleoside analogs targeting viral RNA-dependent RNA polymerase and human RNase L have potent antiviral activity against various human viruses with additional immunomodulatory and anti-inflammatory effects. Anti-inflammation treatment is of pivotal importance and should be timely tailored to the individual patient along with antivirals. Our perspective on the combined antiviral and anti-inflammatory effects of cordycepin and its analogs suggests them as new therapeutics in the treatment of systemic COVID-19 infection.


2003 ◽  
Vol 3 (1) ◽  
pp. 63-64 ◽  
Author(s):  
Y. Ueno ◽  
S. Okatani ◽  
Y. Yamada ◽  
Y. Kitade
Keyword(s):  
Rnase L ◽  

2018 ◽  
Vol 14 (4) ◽  
pp. e1006989 ◽  
Author(s):  
Melissa Drappier ◽  
Babal Kant Jha ◽  
Sasha Stone ◽  
Ruth Elliott ◽  
Rong Zhang ◽  
...  
Keyword(s):  
Rnase L ◽  

2021 ◽  
Vol 118 (22) ◽  
pp. e2101713118
Author(s):  
Jillian N. Whelan ◽  
Nicholas A. Parenti ◽  
Joshua Hatterschide ◽  
David M. Renner ◽  
Yize Li ◽  
...  

Infection with the flavivirus Zika virus (ZIKV) can result in tissue tropism, disease outcome, and route of transmission distinct from those of other flaviviruses; therefore, we aimed to identify host machinery that exclusively promotes the ZIKV replication cycle, which can inform on differences at the organismal level. We previously reported that deletion of the host antiviral ribonuclease L (RNase L) protein decreases ZIKV production. Canonical RNase L catalytic activity typically restricts viral infection, including that of the flavivirus dengue virus (DENV), suggesting an unconventional, proviral RNase L function during ZIKV infection. In this study, we reveal that an inactive form of RNase L supports assembly of ZIKV replication factories (RFs) to enhance infectious virus production. Compared with the densely concentrated ZIKV RFs generated with RNase L present, deletion of RNase L induced broader subcellular distribution of ZIKV replication intermediate double-stranded RNA (dsRNA) and NS3 protease, two constituents of ZIKV RFs. An inactive form of RNase L was sufficient to contain ZIKV genome and dsRNA within a smaller RF area, which subsequently increased infectious ZIKV release from the cell. Inactive RNase L can interact with cytoskeleton, and flaviviruses remodel cytoskeleton to construct RFs. Thus, we used the microtubule-stabilization drug paclitaxel to demonstrate that ZIKV repurposes RNase L to facilitate the cytoskeleton rearrangements required for proper generation of RFs. During infection with flaviviruses DENV or West Nile Kunjin virus, inactive RNase L did not improve virus production, suggesting that a proviral RNase L role is not a general feature of all flavivirus infections.


2005 ◽  
Vol 280 (50) ◽  
pp. 41694-41699 ◽  
Author(s):  
Masayuki Nakanishi ◽  
Nobutada Tanaka ◽  
Yasuaki Mizutani ◽  
Masahiko Mochizuki ◽  
Yoshihito Ueno ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document